Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

New treatments are being explored to slow or reverse hereditary hair loss.

Plant-based antioxidants can help treat hair loss and promote hair growth.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

CEC levels may be a useful marker for predicting prostate cancer progression.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Hirsutism in females is caused by high male hormones or sensitive hair follicles.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.